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ABSTRACT 
Introduction The role of models in supporting health policy decisions is reliant on 
model credibility. Credibility is fundamentally determined by the choices and 
judgements that people make in the process of developing a model. However, the 
method of uncovering choices and making judgements in model development is 
largely unreported and is not addressed by modelling methods guidance.  
Methods This qualitative study was part of a project examining errors in health 
technology assessment models. In-depth interviews with academic and commercial 
modellers were used to obtain descriptions of the model development process.  Data 
were analysed using framework analysis and interpreted in the context of the 
methodological literature.  
Results The activities involved in developing models were characterised according 
to the themes; understanding the decision problem, conceptual modelling, model 
implementation, model checking, and engaging with the decision maker. Finding and 
using evidence was frequently mentioned across these themes. There was marked 
variation between practitioners in the extent to which conceptual modelling was 
recognised as an activity distinct from model implementation.  
Discussion Methodological approaches to addressing model credibility described in 
the wider modelling literature highlight the necessity to disentangle the conceptual 
modelling and implementation activities. Whilst interviewees talked of judgements 
and choice making throughout model development, discussion indicated that these 
were based upon skills and experience with no discussion of formal approaches. 
Methods are required that provide for a systematic approach to uncovering choices, 
to generating a shared view of consensus and divergence, and for making 
judgements and choices in model development. 
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INTRODUCTION 
 
Health technology assessment (HTA) models have been described as mathematical 
models of the natural history, epidemiology and treatment of a disease designed with 
the purpose of predicting how a technology will affect clinically important outcomes.1 
Such models are regularly used by the National Institute for Health and Clinical 
Excellence (NICE) in England and Wales and similar structures internationally in 
supporting health policy decisions and are central to the development and evaluation 
of complex interventions. The key role that models play is, however, reliant on their 
credibility, an issue that has proved to be a perennial and intractable cause for 
concern.2,3 
 
At its most mundane a mathematical model comprises a set of outputs of interest to 
a decision maker, a set of input parameters and a functional relationship between 
these inputs and outputs. However this simple description implies several 
accoutrements including; a set of evidence identified as being relevant to the input 
parameters and functional relationship encapsulated in the model, a set of 
assumptions regarding the nature of that relevance, and a relationship between the 
defined outputs and the decision problem being addressed.  Many choices and 
judgements are involved in composing such a model; choices about the nature of the 
decision problem, the scope and design of the model, choices about modelling 
platform, about data and so on. The HTA model development process is the process 
of making these choices, of uncovering modelling options, of evaluating choices and 
making design judgements and decisions regarding the model. The activities 
associated with making these judgements are not explicitly addressed by current 
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guidelines and they are rarely reported, recognised or discussed in reports of 
modelling studies.4 This paper is about that model development process and its 
importance in establishing the credibility of models. 
 
METHODS 
 
The qualitative study reported here was undertaken as part of a wider project 
examining the understanding of the occurrence of errors in models in the HTA 
modelling community.5 Face-to-face in-depth interviews6 were undertaken between 
September and October 2008. Whilst the interviews were intentionally flexible and 
participant-focussed, a topic guide was designed to facilitate their flow. Interviews 
began with a description of the professional background and organisational context 
within which respondents worked, progressed to an exploration of modeller’s views 
on the modelling process, followed by a discussion of errors throughout the 
modelling process and techniques and strategies for avoiding and preventing such 
errors.  During each of the twelve interviews the modelling process was sketched in 
the form of a process map and validated with the respondent.7 A synthesis meeting 
was held with all the authors to draw together and analyse evidence from the 
process maps. This meeting informed decisions regarding the subsequent qualitative 
process and identified emergent themes from the interviews. Interview transcripts 
were analysed using the inductive thematic Framework approach.8 Respondent 
validation was provided by obtaining feedback from the interviewees on whether the 
findings represented their views.9  This paper reports the qualitative analysis of the 
elements of the interviews focussing on the model development process.  
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Twelve interviewees were drawn from across the HTA modelling community, four 
based in outcomes research organisations involved in making submissions to NICE 
on behalf of the healthcare industry and eight from the academic sector involved in 
preparing reviews for NICE . Two of the eight academic interviewees also referred to 
working for commercial clients in a consultancy role. Five respondents came from an 
economics or health economics background, two from a mathematical background 
and five had an operational research or modelling background. Eleven respondents 
focussed on spreadsheet modelling with Microsoft Excel®, other software platforms 
discussed included the decision analysis software TreeAGE, the discrete event 
simulation package Simul8, and more broadly Crystal Ball, WinBUGS, STATA, 
Delphi, Visual Pascal and SPSS.  
 
RESULTS: THE MODEL DEVELOPMENT PROCESS  
 
The analysis of the interview data provides a description of current model 
development practice as perceived by the interviewees. Process maps were drawn 
up for each interviewee during the interviews, an example map is presented in 
Figure 1 and a full set of maps are presented elsewhere.5  
 
[Figure 1 here] 
 
A generic structure for the model development process was obtained from a 
synthesis of the process maps and included five broad activities; understanding the 
decision problem, conceptual modelling, model implementation, model checking, and 
engaging with the decision. A sixth group of activities related to finding and using 
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evidence was frequently mentioned by the interviewees at different points throughout 
the process presented in Figure 2. A sample of quotes relating to the different 
activities is included in Table 1. 
 
[Figure 2 here] 
[Table 1 here] 
 
Understanding the decision problem 
 
All participants identified the first set of activities in the model development process 
as generating an understanding of the decision problem. Common themes raised by 
the interviewees in this phase were familiarisation with the decision problem, defining 
the research question, understanding the needs of the client and moving towards a 
modelling approach. This phase of the model development process was 
characterised by the rapid parallel development of these themes. 
 
In explicitly considering the definition of the research question interviewees focussed 
on identifying appropriate comparators, interventions, populations and outcomes. 
This reflects the PICO definition of a scope or clearly focussed question arising from 
the evidence based practice movement of Sackett and Cochrane.10,11  Modellers 
also referred to a set of characteristics related to the decision problem that were 
broader than that captured by the research question defined by the PICO statement, 
for instance the disease epidemiology and natural history and the relationship 
between the intervention under consideration and the broader clinical pathway. 
Modellers talked of a process of familiarisation with the decision problem that was 
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typified by an “immersion” in a broad range of potentially relevant evidence 
surrounding the decision problem including looking at previous models, published 
literature and seeking clinical expertise.   
 
Some interviewees took the decision problem as received from the client in the form 
of a ‘draft scope’ or ‘request for proposal’. However most recognised that the 
received decision problem often did not represent the client’s true underlying need or 
did not reflect the underlying clinical decision problem. Most, though not all 
interviewees, took this to imply that a participative approach was therefore necessary 
on behalf of the analysts in assisting with the development of the description of the 
decision problem.  
 
There was a marked variation in the extent to which and speed with which analysts 
moved towards making decision about the modelling methods to be employed, 
though this was frequently cited as an objective of the familiarisation process. Some 
interviewees went as far as identifying ‘key things to go in the model’ whilst others 
immediately jumped to making decisions about modelling methodology and indeed 
referred to the use of early draft models to aid the familiarisation process.  
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Conceptual modelling  
 
Five interviewees explicitly discussed conceptual modelling as a distinct activity from 
model building. The remaining interviewees tended to blur the boundary to varying 
degrees between model construction and conceptual modelling activities, with three 
interviewees appearing to conceptualise and implement models as one model 
building activity.  Whilst there was broad concurrence between the modellers on 
most of the model development process, this variation in the perceived importance of 
conceptual modelling activities constituted the biggest variation in practice identified.   
 
Where conceptual modelling activities were raised, discussion focussed on 
developing a description of the model structure, assumption, health states and 
disease pathways, interpretations of the evidence and the approach to populating 
parameters. Whilst interviewees referred to developing a description of model 
structure, one notable omission was a specific discussion about the selection of 
modelling methodology with most discussions assuming a discrete health state 
simulation or Markov type model.  Many purposes were cited for the conceptual 
modelling activities including fostering agreement between stakeholders, pitching 
and justifying a proposed model, supporting validity checking, as well as trying out 
ideas, getting feedback, “throwing things around” and defining the level of complexity 
in the model. Techniques used in developing the conceptual model included 
developing written documentation, diagrams, sketches and/or clinical/disease 
pathways, memos and model mock-ups.  
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Whilst all modelling exercises clearly entail conceptual activity the important 
distinction revealed by the interviews is the extent to which this is perceived as a 
separate activity from the model implementation. Three respondents that implied no 
distinct conceptual modelling, conceptualised and implemented models as one 
activity. These participants frequently referred to developing “skeleton models” as a 
basis for eliciting information from experts, for testing ideas or to generate an 
expectation of final model results. Conversely some of the respondents would not 
begin model implementation model until a conceptual model had been agreed or 
“signed-off” by the client or experts. For one respondent in particular the vast 
majority of the model development process concerned understanding the decision 
problem and conceptual modelling, with the implementation of a spreadsheet coming 
right at the end of the process.   
 
There was no discussion among the interviewees of formal methods in conceptual 
modelling. Whilst meetings with clinicians / experts were frequently discussed, formal 
or semi-formal methods for structuring such engagements were not discussed. Two 
interviewees suggested that the conceptual modelling skills were usually learned 
through experience and were hard to teach.  
 
Use of information in model development  
 
Interviewees referred to evidence being used to understand, shape and interpret all 
aspects of model development and being obtained from both literature and 
subjective judgement of clinicians and methodologists.  An important source of 
evidence cited for both understanding the decision problem and conceptual 
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modelling was previous models. However, concern was raised that over reliance on 
existing model structures, designed for addressing different decision problems, may 
lead to inappropriate models being used, could stifle innovation and might lead to a 
failure to develop a shared understanding of the current decision problem between 
all stakeholders.  
 
The majority of the interviewees highlighted the existence of a complex iterative 
relationship between model structuring and data identification and use, whereby the 
model structure determines the data requirements to populate the model and the 
availability of evidence in turn influences the structure of the model.  This process of 
arriving at a model structure that provides an adequate framework for relevant 
evidence that remains true to that evidence but has sufficient complexity to address 
the decision problem is the essence of the modelling activity. Several respondents 
mentioned that separation of the systematic review and modelling functions within a 
team hindered model development, preventing the above iterative dynamic. Two 
respondents explicitly recognised the importance of joint working between modellers 
and the other members of the research team and discussed developments within 
their groups to support this process.  
 
Virtually all discussions concerning the process of identifying published literature 
focussed on clinical efficacy evidence; very little discussion was held concerning 
methods for identifying, selecting and using non-efficacy evidence. This was true for 
specifically for evidence pertaining to parameters in the model including costs or 
health-related quality of life, but also true for evidence used in generating an 
understanding of the decision problem, and for evidence used in conceptual 
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modelling. Across all interviewees, it was unclear who holds responsibility for 
identifying, interpreting and analysing such evidence and how such activities differ 
from the identification and use of clinical efficacy data.  
 
Model implementation 
 
All respondents mentioned model implementation. The most common theme raised 
in the discussion was the impact of refining and redefining the conceptual model 
structure during implementation. This issue was primarily concerned with the 
strengths and weaknesses associated with the practice of merging the conceptual 
modelling and model implementation activities but also related to constraints 
imposed by software, skills or experience. One respondent specifically highlighted 
the dangers of implementation by evolution whereby “skeleton models” are 
discussed, amended and develop iteratively. Interviews suggested that model 
building was less iterative for those who agreed the conceptual model prior to 
implementation.  
 
One respondent specifically highlighted the absence of a formal specification and 
design process analogous to that common within software development projects. 
Thus a key link between the conceptual model and implemented model was almost 
completely absent. Such activity would usually include producing a formal model 
specification, including selection of software platforms, details of how the model 
would be programmed, where parameters would be stored and linked, model 
housekeeping and specification of model validation. 
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Model checking 
 
Interviewees made reference to activities relevant to model checking occurring 
throughout the model development process, though most interviewees placed the 
emphasis clearly towards the end of the modelling process. Model checking has the 
potential to trigger major iterations in the whole development cycle, as represented in 
Figure 2. The tenor of comments reflected a minimalist approach to model checking 
activities.  
 
Model checking activities were discussed as either preventing errors from entering 
the model or identifying errors that have occurred. It was noted that often the same 
activity was described as being used prospectively to avoid errors or retrospectively 
to identify errors. Activities were identified as either strategies, expressed by 
interviewees in terms of goals, for example ‘ensure mutual understanding’ or specific 
techniques of implementation. Current strategies for avoiding errors focus on 
ensuring mutual understanding within the analysis team and between the team, 
clients and stakeholders. Strategies include engaging with clinical experts, clients 
and decision-makers and producing written documentation of the proposed model. It 
should be noted that the activities involved with explicit conceptual modelling were 
also explicitly linked to strategies for avoiding errors in models. Techniques include 
using diagrams and sketches, talking through skeleton models with experts, ensuring 
transparency in reporting. Other strategies mentioned by the interviewees focused 
on skills and training of analysts. Techniques for avoiding errors included 
standardised housekeeping approaches in model implementation. Methods reported 
for identifying errors focussed on checking face validity of the structure of the model 
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and outputs, checking the internal consistency and model input values, double-
programming, and peer review. Whilst these methods were clearer than the 
avoidance strategies, in terms of what should actually be done, they were often 
focussed on identifying symptoms indicative of a potential error rather than being 
diagnostic of a definite and specific error. The use of the above activities appeared to 
be partial with a great deal of variation between interviewees and certainly not 
framed within an overall strategy for structuring complex problems. 
 
Engaging with the decision 
 
The majority of interviewees referred to model reporting as the final step in the model 
development process. This stage typically involved report writing, preparation of 
journal manuscripts and engaging with the decision maker in supporting the decision 
making process, for instance participating in committee meetings. Two aspects of 
engaging with the decision making process were recognised, firstly a process of 
building credence in the model amongst the decision maker and secondly a process 
of experimentation in exploring the implications of the model for the decision or 
policy recommendation. The importance of the first aspect of building credibility was 
highlighted strongly by some of the interviewees with this phase frequently feeding 
back into model checking and validation. One interviewee highlighted the need for 
further research in this area focussing on developing methods for most effectively 
presenting results to ensure that key economic messages are communicated 
effectively. 
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DISCUSSION 
 
Early guidelines on HTA modelling explicitly recognised the lack of an established 
approach to model development, acknowledging that little was known about the 
processes and decisions involved.12,13 Subsequent methods documents have 
focussed on standards of reporting, transparency, the definition of a reference case 
to increase methodological comparability between models and on frameworks for 
critical appraisal of models.14,15,16,17,18,19 but have not directly addressed the model 
development process. 
 
This study has led to the identification of a five stage HTA model development 
process, comprising; understanding the decision problem, conceptual modelling, 
model implementation, model checking and engaging with the decision. This process 
broadly captures the views of the modellers interviewed in this study, the major point 
of variation being the degree to which practitioners engage in a set of conceptual 
modelling activities explicitly differentiated from the model implementation activities. 
However, since there must be some conceptual activity involved in the modelling 
process, it is not immediately clear whether identifying this explicitly really matters. 
Whether this is one of those points of practice where we should celebrate the 
diversity of modellers or whether we should be trying to seek some uniformity.   
 
In seeking an answer to this question it is useful to refer back to the motivation for 
the original study, namely to explore methods for identifying and avoiding errors in 
models.5  In discussing the definition of what constitutes an error in a model the HTA 
modellers frequently made reference to an overarching concept of ‘fitness for  
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purpose’ that was broader than straightforward mechanical errors in model 
implementation but included matters of judgment and choice. Several interviewees 
raised the concepts of ‘verification’ and ‘validation’ and where these terms were used 
interviewees were asked to provide definitions. The HTA modellers were wholly 
consistent in their definitions and these were perhaps best captured by one 
interviewee who equated validation with addressing the question “is it the right 
model?” and verification with the question “is the model right?”. These perspectives 
of the HTA modellers resonate strongly with a key strand of methodological literature 
from the modelling domain. In 1979 the Society for Modelling and Simulation 
International (SCS)20 and more recently Sargent21 considered the underpinnings of 
model credibility and defined the distinction between model verification and 
validation, see Box 1. The interviewees’ concept of ‘fitness for purpose’ is almost a 
precise corollary of the SCS ‘model credibility’, though it should be noted that the 
term ‘credibility’ did not occur in any of the interviews. Furthermore, whilst the HTA 
modellers’ notion of validation appears to conflate the SCS definitions of credibility 
and validation, the interviewees concept of verification matches almost precisely with 
the SCS definition. However this common agreed definition of verification relies on 
there being an explicit and complete description of the conceptual model. Where the 
description of the conceptual model is absent or incomplete this separation between 
the concepts of verification and validation breaks down. Thus formal approaches to 
disentangling model credibility or fitness for purpose require us to disentangle the 
conceptual modelling activities and programming activities. This is necessary to 
allow us to develop quality assurance mechanisms that recognise the fundamentally 
different nature of these activities.  
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[Box 1 here] 
 
‘Understanding the decision problem’ and ‘conceptual modelling’ form fundamental 
modelling activities in the process. A common aspect of the interview discussions for 
these two activities is the focus on general principles rather than methods. For 
example whilst interviewees noted that “mechanisms for ensuring clarity were useful” 
none of the interviewees referred to any specific mechanisms beyond ensuring 
adequate clinical input. Methods are required that provide for a systematic approach 
to uncovering choices, to generating a shared view of consensus and divergence, 
and for making judgements and choices. To date the HTA domain has been 
successful in drawing on Operational Research or decision science methods 
including decision analysis, simulation and utility theory. A further set of methods that 
may provide some traction in addressing the above problems are the Operational 
Research techniques for structuring complex problems. Three potentially relevant 
methods that may provide a starting point for further development are Soft Systems 
Methodology, cognitive mapping and Strategic Choice Approach.   
 
Soft Systems Methodology provides a method for structuring enquiry and defining a 
problem domain, captured by its simple CATWOE mnemonic checklist (see Box 2).22 
Comparing the PICO statement and the CATWOE mnemonic raises a number of 
issues. Firstly the CATWOE definition is broader than the PICO definition of scope 
and captures many of the ingredients discussed by interviewees within the realm of 
problem familiarisation. Further this approach makes explicit a number of issues that 
appear to be assumed within the HTA context, thus for instance the interviews stated 
or implied that the role of HTA decision modelling was to estimate the cost 
 18 
effectiveness of interventions. This assumption may well be appropriate in the 
majority of assessments where the problem customers and actors are within the 
health domain and subject to direct influence of health commissioning policy makers. 
However in more complex systems for example involving public health it may be 
important for modelling to capture the specific economic perspective of owners of a 
system.   
 
[Box 2 here] 
 
Another Operational Research method used for achieving clarity in problem 
structuring is cognitive or causal mapping.23 This method provides an approach to 
elucidating the causal linkages between constructs within a problem domain. The 
approach was originally developed as a tool for mapping the cognition of an 
individual expert which in itself would justify its relevance. However the technique 
can equally be used to map the expert judgment of groups or text based evidence 
and has been used in other domains of public sector policy analysis.24  The focus of 
cognitive mapping on retaining and managing complexity as opposed to simplifying 
complexity out of the problem suggests its usefulness for supporting judgments 
about the appropriate level of detail to include in a model. Two examples 
demonstrating the potential of cognitive mapping are the ‘Foresight’ obesity 
modelling that has informed recent national strategic policy making,25 and a review 
on improving health outcomes for looked after children undertaken for the NICE 
public health programme. (Publication withheld until NICE public health evidence 
consultation).  
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Strategic Choice Approach provides a method for making choices under uncertainty. 
It allows “more confident progress towards decisions by focusing our attention on 
possible ways of managing uncertainty”.26 The method identifies three types of 
uncertainty in choice and focuses on achieving transparency in the method for 
choosing; including criteria for choice, the judgments underpinning our choice and 
the process for uncovering options. A pilot study of the use of the Strategic Choice 
Approach in making decisions about model structure has been undertaken as part of 
a HTA for NICE.27 This pilot study identified and evaluated model options for linking 
short term trial outcomes to long term economic outcomes and examined the 
feasibility of using such an approach in this setting.    
 
This investigation arose from a qualitative study investigating the occurrence of 
errors in HTA models. Interviewees were asked to describe the model development 
process purely in order to provide a framework or structure for the subsequent 
discussion of the creation of errors in models. However, it emerged from the analysis 
that the model development process itself, including the choices and judgements 
involved in constructing the model, were fundamentally important in determining the 
credibility of a model for decision making. This paper has identified a description of 
the modelling process that provides a starting point for clarifying the nature of these 
choices and judgements and the development of methods for approaching these 
choices and judgements systematically.  
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Table 1: Interviewee quotes illustrating model development activities 
 
Quote Modelling activity 
“You start by just immersing yourself in whatever you can 
find that gives you an understanding of all the basics.  
What is the disease,  where does it come from, what’s its 
natural progression, who gets it, why. Then begin to focus 
down on what is the decision problem,  what are you 
looking to compare with what, under what 
circumstances?” 
Understanding 
the decision 
problem 
“In the NICE situation, you’ve read your scope you think 
you know what it’s about.  But then you start reading… 
and you think, “Oh!  This is more complicated than I 
thought.” 
“you get an RFP (request for proposal)  which is by no 
means clear…and it wont be very helpful to rush off and 
start to develop any kind of model on that platform… you 
answer the question that they asked and they then decide 
that was not the question they had in mind so certain 
processes of ensuring clarity are useful” 
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“it’s the process of becoming knowledgeable about what 
you are going to be modelling…reading the background 
literature, knowing what the disease process is, knowing 
the clinical pathway that typically or pathways typically 
that patients experience within the situation you are 
modelling. Going to see clinical experts to ask questions 
and find out more and gradually hone in on an 
understanding on the clinical area being studied in a way 
that enables you to begin to represent it systematically” 
“…I think it’s a judgement call that modellers are 
constantly forced to make. What level of simplification… is 
appropriate for the modelling process? I think what’s very 
important is to continually refer back to the decision that 
you are hoping to support with your model. So don’t try 
and answer questions that aren’t going to be asked…” 
Conceptual 
modelling 
“So every aspect of what you… need to programme and 
populate  is… in people’s brains to various degrees… if 
you get all that agreed, then the actual implementation in 
Excel should be pretty straightforward.  But if that process 
has taken you 90% of your time, then… you build a model 
pretty quickly." 
“I don’t think… that I can sit here and write out how you 
build a model.  I think it’s something which comes with 
experience”  
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“there is a danger that…if you just slavishly adopt a 
previous structure…and everybody does the same there’s 
no potential for better structures to develop or for 
mistakes to be appealed” 
Use of 
information 
“I divide it between design and populate… the populating 
being locating the information to actually parameterise 
those relationships and then going back and changing the 
relationships to ones that you can actually parameterise 
from the data that’s available, and then changing the data 
that you look for to fit your revised view of the world” 
“I think things are … kind of trying to be changed.  I’m not 
seeing a systematic review… as something separate from 
modelling; now they are working together and defining 
what [it] is… that we are looking for together.” 
“…whether its adding something in or taking something 
out there is the worry at the back of your mind that its 
going to affect something else in a way that perhaps you 
don’t observe … there is a danger if you make the 
decision to include or exclude definitively that you might 
regret it later on…” 
Model 
implementation 
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“…you don’t want to keep on rebuilding your model, … 
most of the big issues I see are all about the sort of 
thought processes behind defining that decision problem, 
defining the structure, defining the core set of 
assumptions...  if we can get agreement about that, the 
implementation of it is really straightforward.” 
“Either the intuition or the modelling or the data is wrong 
and we tend to assume that it is only one of them … I 
think you tend to assume that once they're [clinical 
experts] not surprised by the thing then, that means you 
have got it right.” 
Model checking 
“So we do just enough … just enough but not as much as 
you’d want to do”  
“we need to pay more attention to understanding how our 
models are understood and how we present them…in 
ensuring everyone has a clear view of what’s being said. 
There are ways in which model outputs can be more 
transparently depicted and the key messages conveyed to 
users more clearly.” 
Engaging with 
the decision 
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Figure 1:  Example modelling process map captured at interview  
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Figure 2:  The model development process  
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Box 1: Society for Modelling and Simulation International (SCS) 
definition of validation and verification20 
 
Validation substantiation that a computerised model 
within its domain of applicability possesses a 
satisfactory range of accuracy consistent 
with the intended application of the model 
Verification substantiation that a computerised model 
represents a conceptual model within 
specified limits of accuracy 
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Box 2: CATWOE checklist for structured investigation of a decision 
problem  
  C = Customers  
 Who is on the receiving end?  
 What problem do they have now?  
 How will they react to what you are proposing?  
 Who are the winners and losers?  
  A = Actors  
 Who are the actors who will 'do the doing', carrying out the solution?  
 What is the impact on them?  
 How might they react?  
  T = Transformation process  
 What is the process for transforming inputs into outputs?  
 What are the inputs? Where do they come from?  
 What are the outputs? Where do they go to?  
 What are all the steps in between?  
  W = World View  
 What is the bigger picture into which the situation fits?  
 What is the real problem you are working on?  
 What is the wider impact of any solution?  
  O = Owner  
 Who is the real owner of the process or situation you are changing?  
 Can they help you or stop you?  
 What would cause them to get in your way?  
 What would lead them to help you?  
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  E = Environmental constraints  
 What are the broader constraints that act on the situation?  
 What are the ethical limits, the laws and so on ? 
 What are the financial, resource constraints? 
 How can you release these constraints?   
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